Repligen | RGEN - EPS Earnings Per Share

Stock Price
117.60
Daily Change
3.54 3.10%
Monthly
2.87%
Yearly
-18.76%
Q2 Forecast
115.08

Repligen reported $0.49 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 0.39 0.39 May/05
FY2025Q4 Dec/2025 0.49 0.44 0.44 Feb/24
FY2025Q3 Sep/2025 0.46 0.42 0.43 Oct/28
FY2025Q2 Jun/2025 0.37 0.39 0.33 Jul/29
FY2025Q1 Mar/2025 0.39 0.35 0.28 Apr/29




Eps Change Date
Agilent USD 1.32 0.35 Dec/2025
Align Technology USD 3.29 0.68 Dec/2025
Bio Techne USD 0.46 0.04 Dec/2025
BioMarin Pharmaceutical USD 0.46 0.34 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Bruker USD 0.59 0.14 Dec/2025
Charles River Laboratories USD 2.39 0.04 Dec/2025
Danaher USD 2.06 0.17 Mar/2026
Dentsply International USD 0.06 0.44 Dec/2025
General Electric Aerospace USD 1.86 0.29 Mar/2026
Henry Schein USD 1.34 0.04 Dec/2025
Illumina USD 1.35 0.01 Dec/2025
IQVIA Holdings USD 3.42 0.42 Dec/2025
Mettler Toledo International USD 13.36 2.21 Dec/2025
Myriad Genetics USD 0.04 0.33 Dec/2025
OraSure Technologies USD -0.18 0 Dec/2025
Pacific Biosciences Of California USD -0.17 0.12 Dec/2025
Pfizer USD 0.66 0.21 Dec/2025
Repligen USD 0.49 0.03 Dec/2025
Revvity USD 1.7 0.52 Dec/2025
Standard Biotools USD 0.04 0.13 Dec/2025
Thermo Fisher Scientific USD 5.44 1.13 Mar/2026
Waters USD 4.53 1.13 Dec/2025
West Pharmaceutical Services USD 2.13 0.09 Mar/2026